Literature DB >> 9420251

The viral spike protein is not involved in the polarized sorting of coronaviruses in epithelial cells.

J W Rossen1, R de Beer, G J Godeke, M J Raamsman, M C Horzinek, H Vennema, P J Rottier.   

Abstract

Coronaviruses are assembled by budding into a pre-Golgi compartment from which they are transported along the secretory pathway to leave the cell. In cultured epithelial cells, they are released in a polarized fashion; depending on the virus and cell type, they are sorted preferentially either to the apical domain or to the basolateral plasma membrane domain. In this study, we investigated the role of the coronavirus spike protein, because of its prominent position in the virion the prime sorting candidate, in the directionality of virus release. Three independent approaches were taken. (i) The inhibition of N glycosylation by tunicamycin resulted in the synthesis of spikeless virions. The absence of spikes, however, did not influence the polarity in the release of virions. Thus, murine hepatitis virus strain A59 (MHV-A59) was still secreted from the basolateral membranes of mTAL and LMR cells and from the apical sides of MDCK(MHVR) cells, whereas transmissible gastroenteritis virus (TGEV) was still released from the apical surfaces of LMR cells. (ii) Spikeless virions were also studied by using the MHV-A59 temperature-sensitive mutant Albany 18. When these virions were produced in infected LMR and MDCK(MHVR) cells at the nonpermissive temperature, they were again preferentially released from basolateral and apical membranes, respectively. (iii) We recently demonstrated that coronavirus-like particles resembling normal virions were assembled and released when the envelope proteins M and E were coexpressed in cells (H. Vennema, G.-J. Godeke, J. W. A. Rossen, W. F. Voorhout, M. C. Horzinek, D.-J. E. Opstelten, and P. J. M. Rottier, EMBO J. 15:2020-2028, 1996). The spikeless particles produced in mTAL cells by using recombinant Semliki Forest viruses to express these two genes of MHV-A59 were specifically released from basolateral membranes, i.e., with the same polarity as that of wild-type MHV-A59. Our results thus consistently demonstrate that the spike protein is not involved in the directional sorting of coronaviruses in epithelial cells. In addition, our observations with tunicamycin show that contrary to the results with some secretory proteins, the N-linked oligosaccharides present on the viral M proteins of coronaviruses such as TGEV also play no role in viral sorting. The implications of these conclusions are discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9420251      PMCID: PMC109400     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Transmissible gastroenteritis of swine: virus-intestinal cell interactions. I. Immunofluorescence, histopathology and virus production in the small intestine through the course of infection.

Authors:  M Pensaert; E O Haelterman; T Burnstein
Journal:  Arch Gesamte Virusforsch       Date:  1970

2.  Coronavirus E1 glycoprotein expressed from cloned cDNA localizes in the Golgi region.

Authors:  P J Rottier; J K Rose
Journal:  J Virol       Date:  1987-06       Impact factor: 5.103

3.  Coronavirus M proteins accumulate in the Golgi complex beyond the site of virion budding.

Authors:  J Klumperman; J K Locker; A Meijer; M C Horzinek; H J Geuze; P J Rottier
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

4.  Overexpression of the MHV receptor. Effect on progeny virus secretion.

Authors:  T M Gallagher
Journal:  Adv Exp Med Biol       Date:  1995       Impact factor: 2.622

5.  A new generation of animal cell expression vectors based on the Semliki Forest virus replicon.

Authors:  P Liljeström; H Garoff
Journal:  Biotechnology (N Y)       Date:  1991-12

6.  Apical secretion of hepatitis B surface antigen from transfected Madin-Darby canine kidney cells.

Authors:  A González; S Nicovani; F Juica
Journal:  J Biol Chem       Date:  1993-03-25       Impact factor: 5.157

7.  Interaction of mouse hepatitis virus (MHV) spike glycoprotein with receptor glycoprotein MHVR is required for infection with an MHV strain that expresses the hemagglutinin-esterase glycoprotein.

Authors:  S Gagneten; O Gout; M Dubois-Dalcq; P Rottier; J Rossen; K V Holmes
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

8.  Constitutive apical secretion of an 80-kD sulfated glycoprotein complex in the polarized epithelial Madin-Darby canine kidney cell line.

Authors:  J Urban; K Parczyk; A Leutz; M Kayne; C Kondor-Koch
Journal:  J Cell Biol       Date:  1987-12       Impact factor: 10.539

9.  A conditional-lethal murine coronavirus mutant that fails to incorporate the spike glycoprotein into assembled virions.

Authors:  C S Ricard; C A Koetzner; L S Sturman; P S Masters
Journal:  Virus Res       Date:  1995-12       Impact factor: 3.303

10.  TGEV corona virus ORF4 encodes a membrane protein that is incorporated into virions.

Authors:  M Godet; R L'Haridon; J F Vautherot; H Laude
Journal:  Virology       Date:  1992-06       Impact factor: 3.616

View more
  23 in total

1.  Supramolecular architecture of severe acute respiratory syndrome coronavirus revealed by electron cryomicroscopy.

Authors:  Benjamin W Neuman; Brian D Adair; Craig Yoshioka; Joel D Quispe; Gretchen Orca; Peter Kuhn; Ronald A Milligan; Mark Yeager; Michael J Buchmeier
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

2.  Apical budding of a recombinant influenza A virus expressing a hemagglutinin protein with a basolateral localization signal.

Authors:  Rosalia Mora; Enrique Rodriguez-Boulan; Peter Palese; Adolfo García-Sastre
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

Review 3.  Update on treatment and preventive interventions against COVID-19: an overview of potential pharmacological agents and vaccines.

Authors:  Yinan Xiao; Hanyue Xu; Wen Guo; Yunuo Zhao; Yuling Luo; Ming Wang; Zhiyao He; Zhenyu Ding; Jiyan Liu; Lei Deng; Fushen Sha; Xuelei Ma
Journal:  Mol Biomed       Date:  2020-12-03

4.  Coronavirus spike glycoprotein, extended at the carboxy terminus with green fluorescent protein, is assembly competent.

Authors:  Berend Jan Bosch; Cornelis A M de Haan; Peter J M Rottier
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

5.  Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody.

Authors:  Dora Pinto; Young-Jun Park; Martina Beltramello; Alexandra C Walls; M Alejandra Tortorici; Siro Bianchi; Stefano Jaconi; Katja Culap; Fabrizia Zatta; Anna De Marco; Alessia Peter; Barbara Guarino; Roberto Spreafico; Elisabetta Cameroni; James Brett Case; Rita E Chen; Colin Havenar-Daughton; Gyorgy Snell; Amalio Telenti; Herbert W Virgin; Antonio Lanzavecchia; Michael S Diamond; Katja Fink; David Veesler; Davide Corti
Journal:  Nature       Date:  2020-05-18       Impact factor: 49.962

6.  Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion.

Authors:  Alexandra C Walls; Xiaoli Xiong; Young-Jun Park; M Alejandra Tortorici; Joost Snijder; Joel Quispe; Elisabetta Cameroni; Robin Gopal; Mian Dai; Antonio Lanzavecchia; Maria Zambon; Félix A Rey; Davide Corti; David Veesler
Journal:  Cell       Date:  2019-01-31       Impact factor: 66.850

Review 7.  Influenza virus morphogenesis and budding.

Authors:  Debi P Nayak; Rilwan A Balogun; Hiroshi Yamada; Z Hong Zhou; Subrata Barman
Journal:  Virus Res       Date:  2009-05-27       Impact factor: 3.303

Review 8.  Glycosylation of SARS-CoV-2: structural and functional insights.

Authors:  Asif Shajahan; Lauren E Pepi; Daniel S Rouhani; Christian Heiss; Parastoo Azadi
Journal:  Anal Bioanal Chem       Date:  2021-07-07       Impact factor: 4.478

Review 9.  Identification of Novel Candidate Epitopes on SARS-CoV-2 Proteins for South America: A Review of HLA Frequencies by Country.

Authors:  David Requena; Aldhair Médico; Ruy D Chacón; Manuel Ramírez; Obert Marín-Sánchez
Journal:  Front Immunol       Date:  2020-09-03       Impact factor: 7.561

10.  Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2.

Authors:  Alexandra C Walls; Brooke Fiala; Alexandra Schäfer; Samuel Wrenn; Minh N Pham; Michael Murphy; Longping V Tse; Laila Shehata; Megan A O'Connor; Chengbo Chen; Mary Jane Navarro; Marcos C Miranda; Deleah Pettie; Rashmi Ravichandran; John C Kraft; Cassandra Ogohara; Anne Palser; Sara Chalk; E-Chiang Lee; Elizabeth Kepl; Cameron M Chow; Claire Sydeman; Edgar A Hodge; Brieann Brown; Jim T Fuller; Kenneth H Dinnon; Lisa E Gralinski; Sarah R Leist; Kendra L Gully; Thomas B Lewis; Miklos Guttman; Helen Y Chu; Kelly K Lee; Deborah H Fuller; Ralph S Baric; Paul Kellam; Lauren Carter; Marion Pepper; Timothy P Sheahan; David Veesler; Neil P King
Journal:  bioRxiv       Date:  2020-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.